Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AzurRx BioPharma Inc. (AZRX)

0.803   -0.017 (-2.07%) 05-29 16:00
Open: 0.86 Pre. Close: 0.82
High: 0.86 Low: 0.7701
Volume: 276,456 Market Cap: 23M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.85 - 0.856 0.856 - 0.86
Low: 0.788 - 0.794 0.794 - 0.8
Close: 0.811 - 0.82 0.82 - 0.828

Technical analysis

as of: 2020-05-29 3:24:11 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.03     One year: 1.25
Support: Support1: 0.58    Support2: 0.48
Resistance: Resistance1: 0.88    Resistance2: 1.07
Pivot: 0.85
Moving Average: MA(5): 0.83     MA(20): 0.81
MA(100): 0.82     MA(250): 0.94
MACD: MACD(12,26): 0.05     Signal(9): 0.06
Stochastic oscillator: %K(14,3): 24.25     %D(3): 35.96
RSI: RSI(14): 49.64
52-week: High: 2.29  Low: 0.37  Change(%): -65.2
Average Vol(K): 3-Month: 28598  10-Days: 23093

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
AZRX has closed above bottom band by 17.9%. Bollinger Bands are 36.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 29 May 2020
Here is What Hedge Funds Think About AzurRx BioPharma, Inc. (AZRX) - Yahoo Finance

Thu, 07 May 2020
AzurRx BioPharma Announces Entry into Packaging, Labeling and Distribution Agreement with Creapharm Clinical Supplies for MS1819 Clinical Trial Drug Product - GlobeNewswire

Wed, 20 May 2020
How Does AzurRx BioPharma Inc (AZRX) Stock Rank on Wall Street? - InvestorsObserver

Wed, 13 May 2020
Analysts Turn Mixed On AzurRx BioPharma Inc. (NASDAQ:AZRX), Urban Edge Properties (NYSE:UE) - State Reviewer

Wed, 27 May 2020
AzurRx BioPharma Inc How Have the Numbers Shaped Up for - Stock Market Daily

Thu, 07 May 2020
Is There A Value in AzurRx BioPharma Inc. (NASDAQ:AZRX) And Pearson plc (NYSE:PSO) - State Reviewer

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 28
Shares Float (M) 25
% Held by Insiders 17.79
% Held by Institutions 5.11
Shares Short (K) 85
Shares Short P. Month (K) 58

Stock Financials

EPS -0.638
EPS Est This Year -0.850
EPS Est Next Year -0.670
Book Value (p.s.) 0.110
Profit Margin
Operating Margin
Return on Assets (ttm) -95.3
Return on Equity (ttm) -548.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.443
Qtrly Earnings Growth
Operating Cash Flow (M) -13
Levered Free Cash Flow (M) -7

Stock Valuations

PE Ratio -1.22
PEG Ratio
Price to Book value 7.09
Price to Sales
Price to Cash Flow -1.73

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.